Abstract
Background: It is often difficult to detect a local recurrence of soft-tissue sarcomas due to disturbance of the normal anatomy by previous surgery and radiotherapy. The aim of this study was to assess the value of positron emission tomography (PET) with [18F]fluoro-2-deoxy-d-glucose (FDG) for detecting local recurrences.
Methods: In the period 1992–1995, 17 patients with proven or suspected local recurrence of soft-tissue sarcoma were examined using FDG-PET. Fifteen of these patients were ultimately proven to have a recurrence.
Results: Recurrence was visualized in 14 patients (93%). Small tumors (maximum diameter 0.5 cm) were as easily visible as large lesions (maximum diameter 20 cm). In one patient the PET scan was positive, but the recurrence could not be proven histologically. Recurrence was proven 1 year later. A recurrent low-grade liposarcoma was not visualized. The two patients with benign lesions had a negative PET scan. The mean glucose metabolic rate was calculated to be 13.2 µmol/100 g/min (range 1.9–28.4). A correlation was found between the histological malignancy grade and the metabolic rate (p<0.05; Kruskal-Wallis).
Conclusion: PET with FDG is a useful addition to the diagnostic armamentarium for detecting local recurrence of soft-tissue sarcomas and provides an indication of the malignancy grade of the recurrent lesion.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Lawrence W Jr, Donegan WL, Natarajan N, Mettlin C, Beart R, Winchester D. Adult soft tissue sarcomas. A pattern of care survey of the American College of Surgeons.Ann Surg 1987;205:349–59.
Hoekstra HJ, Schraffordt Koops H, Oldhoff J. Soft tissue sarcoma of the extremity.Eur J Surg Oncol 1994;20:3–6.
Hogeboom WR, Hoekstra HJ, Mooyaart EL, Freling NJM, Schraffordt Koops H. MRI and CT in the preoperative evaluation of soft tissue tumors.Arch Orthop Trauma Surg 1991;110:162–4.
Warburg O. On the origin of cancer cells.Science 1956;123:309–14.
Strauss LG, Conti PS. The applications of PET in clinical oncology.J Nucl Med 1991;32:623–48.
Nieweg OE, Kim EE, Wong WH, et al. Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer.Cancer 1993;71:3920–5.
Patronas NJ, Di Chiro G, Brooks RA, et al. Work in progress: (18F) fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.Radiology 1982;144:885–9.
Strauss LG, Clorius JH, Schlag P, et al. Recurrence of colorectal tumors: PET evaluation.Radiology 1989;170:329–32.
Ichiya Y, Kuwabara Y, Otsuka M, et al. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.J Nucl Med 1991;32:1655–60.
Kim EE, Chung S-K, Haynie TP, et al. Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET.Radiographics 1992;12:269–79.
Kern KA, Brunetti A, Norton JA, et al. Metabolic imaging of human extremity musculoskeletal tumors by PET.J Nucl Med 1988;29:181–6.
Nieweg OE, Pruim J, Van Ginkel RJ, et al. Positron emission tomography with18F-fluorodeoxyglucose for soft tissue sarcoma.J Nucl Med 1996;37:257–61.
Coindre JM, Trojani M, Contesso G, et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma.Cancer 1986;58:306–9.
Enzinger FM, Weiss SW.Soft tissue tumors. St. Louis: CV Mosby, 1988.
Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of no-carrier added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution.J Nucl Med 1986;27:235–8.
Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.J Cereb Blood Flow Metab 1983;3:1–7.
Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations.J Cereb Blood Flow Metab 1985;5:584–90.
Hudson TM, Schakel M, Springfield DS. Limitations of computed tomography following excisional biopsy of soft tissue sarcomas.Skeletal Radiol 1985;13:49–54.
Weekes RG, Berquist TH, McLeod RA, Zimmer WD. Magnetic resonance imaging of soft-tissue tumors: comparison with computed tomography.Magn Reson Imaging 1985;3:345–52.
Hoekstra HJ, Boeve WJ, Kamman RL, Mooyaart EL. Clinical applicability of human in vivo localized phosphorus-31 magnetic resonance spectroscopy of bone and soft tissue tumors.Ann Surg Oncol 1994;1:504–11.
Reuther G, Mutschler W. Detection of local recurrent disease in musculoskeletal tumors: magnetic resonance imaging versus computed tomography.Skeletal Radiol 1990;19:85–90.
Adler LP, Blair HF, Makley JT, et al. Noninvasive grading of musculoskeletal tumors using PET.J Nucl Med 1991;32:1508–12.
Di Chiro G, DeLaPaz RL, Brooks RA, et al. Glucose utilization of cerebral gliomas measured by (18F) fluorodeoxyglucose and positron emission tomography.Neurology 1982;32:1323–9.
Leskinen-Kallio S, Ruotsalainen U, Nagren K, Teras M, Joensuu H. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study.J Nucl Med 1991;32:1211–8.
Minn H, Joensuu H, Ahonen A, Klemi P. Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors.Cancer 1988;61:1776–81.
Haberkorn U, Strauss LG, Reisser C, et al. Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry.J Nucl Med 1991;32:1548–55.
Alavi JB, Alavi A, Chawluk J, Kushner M, Powe J, Hickey W, Reivich M. Positron emission tomography in patients with glioma. A predictor of prognosis.Cancer 1988;62:1074–8.
Okada J, Yoshikawa K, Imazeki K, et al. The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis.J Nucl Med 1991;32:686–91.
Griffeth LK, Dehdashti F, McGuire AH, et al. PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose.Radiology 1992;182:185–94.
Adler LP, Blair HF, Williams RP, et al. Grading liposarcomas with PET using [18F]FDG.J Comput Assist Tomogr 1990;14:960–2.
Nieweg OE. Potential applications of positron emission tomography in surgical oncology: a review.Eur J Surg Oncol 1994;20:415–24.
Hawkins RA, Hoh C, Dahlbom M, et al. PET cancer evaluations with FDG.J Nucl Med 1991;32:1555–8.
Pollock RE. Evaluation and treatment of soft-tissue sarcoma.Cancer Bull 1992;44:268–74.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kole, A.C., Nieweg, O.E., van Ginkel, R.J. et al. Detection of local recurrence of soft-tissue sarcoma with positron emission tomography using [18F]fluorodeoxyglucose. Annals of Surgical Oncology 4, 57–63 (1997). https://doi.org/10.1007/BF02316811
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02316811